813 related articles for article (PubMed ID: 30667296)
21. "Block-and-replace" treatment in Graves' disease: experience in a cohort of pediatric patients.
Vigone MC; Peroni E; Di Frenna M; Mora S; Barera G; Weber G
J Endocrinol Invest; 2020 May; 43(5):595-600. PubMed ID: 31713721
[TBL] [Abstract][Full Text] [Related]
22. Treatment Modality and Risk of Heart Failure in Patients With Long-Standing Graves' Disease: A Nationwide Population-Based Cohort Study.
Song E; Kim M; Park S; Park MJ; Kim JA; Roh E; Yu JH; Kim NH; Seo JA; Kim SG; Kim NH; Choi KM; Baik SH; Yoo HJ
Front Endocrinol (Lausanne); 2021; 12():761782. PubMed ID: 34690936
[TBL] [Abstract][Full Text] [Related]
23. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
[TBL] [Abstract][Full Text] [Related]
24. Graves' Disease: Can It Be Cured?
Wiersinga WM
Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
[TBL] [Abstract][Full Text] [Related]
25. Management of recurrent hyperthyroidism in patients with Graves' disease treated by subtotal thyroidectomy.
Sugino K; Mimura T; Ozaki O; Iwasaki H; Wada N; Matsumoto A; Ito K
J Endocrinol Invest; 1995 Jun; 18(6):415-9. PubMed ID: 7594234
[TBL] [Abstract][Full Text] [Related]
26. Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy.
Yoshihara A; Iwaku K; Noh JY; Watanabe N; Kunii Y; Ohye H; Suzuki M; Matsumoto M; Suzuki N; Tadokoro R; Sekiyama C; Hiruma M; Sugino K; Ito K
Thyroid; 2019 Jan; 29(1):128-134. PubMed ID: 30426886
[TBL] [Abstract][Full Text] [Related]
27. Impaired immune regulation after radioiodine therapy for Graves' disease and the protective effect of Methimazole.
Côté-Bigras S; Tran V; Turcotte S; Rola-Pleszczynski M; Verreault J; Rottembourg D
Endocrine; 2016 Jun; 52(3):587-96. PubMed ID: 26701678
[TBL] [Abstract][Full Text] [Related]
28. Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.
Sundaresh V; Brito JP; Wang Z; Prokop LJ; Stan MN; Murad MH; Bahn RS
J Clin Endocrinol Metab; 2013 Sep; 98(9):3671-7. PubMed ID: 23824415
[TBL] [Abstract][Full Text] [Related]
29. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
Villagelin D; Romaldini JH; Santos RB; Milkos AB; Ward LS
Thyroid; 2015 Dec; 25(12):1282-90. PubMed ID: 26414885
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
Chen DY; Chen TH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
[TBL] [Abstract][Full Text] [Related]
31. Quality of life in patients with benign nontoxic goiter: impact of disease and treatment response, and comparison with the general population.
Cramon P; Bonnema SJ; Bjorner JB; Ekholm O; Feldt-Rasmussen U; Frendl DM; Groenvold M; Hegedüs L; Rasmussen ÅK; Watt T
Thyroid; 2015 Mar; 25(3):284-91. PubMed ID: 25602312
[TBL] [Abstract][Full Text] [Related]
32. Treatment of Graves' hyperthyroidism: evidence-based and emerging modalities.
Hegedüs L
Endocrinol Metab Clin North Am; 2009 Jun; 38(2):355-71, ix. PubMed ID: 19328416
[TBL] [Abstract][Full Text] [Related]
33. Selenium supplementation for patients with Graves' hyperthyroidism (the GRASS trial): study protocol for a randomized controlled trial.
Watt T; Cramon P; Bjorner JB; Bonnema SJ; Feldt-Rasmussen U; Gluud C; Gram J; Hansen JL; Hegedüs L; Knudsen N; Bach-Mortensen P; Nolsøe R; Nygaard B; Pociot F; Skoog M; Winkel P; Rasmussen AK
Trials; 2013 Apr; 14():119. PubMed ID: 23782950
[TBL] [Abstract][Full Text] [Related]
34. The tale of radioiodine and Graves' orbitopathy.
Ponto KA; Zang S; Kahaly GJ
Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895
[TBL] [Abstract][Full Text] [Related]
35. Radioiodine therapy versus antithyroid medications for Graves' disease.
Ma C; Xie J; Wang H; Li J; Chen S
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
[TBL] [Abstract][Full Text] [Related]
36. Definitive treatment of Graves' disease in children and adolescents.
Król A; Czarniecka A; Jarząb B
Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
[TBL] [Abstract][Full Text] [Related]
37. Total thyroidectomy (Tx) versus thionamides (antithyroid drugs) in patients with moderate-to-severe Graves' ophthalmopathy - a 1-year follow-up: study protocol for a randomized controlled trial.
Brammen L; Riss P; Lukas J; Gessl A; Dunkler D; Li S; Leisser A; Rezar-Dreindl S; Eibenberger K; Selberherr A; Scheuba C; Papp A
Trials; 2018 Sep; 19(1):495. PubMed ID: 30219088
[TBL] [Abstract][Full Text] [Related]
38. Management of Graves' hyperthyroidism: present and future.
Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
[TBL] [Abstract][Full Text] [Related]
39. Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
Okosieme OE; Taylor PN; Evans C; Thayer D; Chai A; Khan I; Draman MS; Tennant B; Geen J; Sayers A; French R; Lazarus JH; Premawardhana LD; Dayan CM
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):278-287. PubMed ID: 30827829
[TBL] [Abstract][Full Text] [Related]
40. Long-term follow-up result of antithyroid drug treatment of Graves' hyperthyroidism in a large cohort.
Jin M; Jang A; Kim CA; Kim TY; Kim WB; Shong YK; Jeon MJ; Kim WG
Eur Thyroid J; 2023 Apr; 12(2):. PubMed ID: 36826832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]